Publish date:

Monday's Health Winners & Losers

BioCryst Pharmaceuticals is rising.

BioCryst Pharmaceuticals

(BCRX) - Get BioCryst Pharmaceuticals, Inc. Report

was rising after the H5N1 strain of the bird flu disease was confirmed in the U.K., leading to the destruction of 159,000 turkeys in the country. BioCryst, which manufactures vaccines for the bird flu, was rising 64 cents, or 6.3%, to $10.75.

Amylin Pharmaceuticals


was higher by $1.07, or 2.8%, to $39.64 after Leerink Swann upgraded the stock to outperform from market perform.

Shares of

Columbia Laboratories


plummeted 67.3% after the company said a clinical trial of a drug failed to prevent preterm births in a late-stage study. Columbia Laboratories was losing $3.10 to $1.51.

Shares of

Vertex Pharmaceuticals

(VRTX) - Get Vertex Pharmaceuticals Incorporated Report

slumped another 3%, extending Friday's 3% loss. On Thursday, the company said it expects losses to widen in 2007 as it invests more in its hepatitis C drug. Vertex was losing $1 to $32.73.

Among health care stocks gaining ground,



was rising 6.6% to $5.96,

TheStreet Recommends


(XOMA) - Get XOMA Corporation Report

was gaining 5.2% at $2.82, and

Millennium Pharmaceuticals


was higher by 1% to $11.25.

As for decliners,


(ILMN) - Get Illumina, Inc. (ILMN) Report

was sinking 3.9% to $35.71,



was shedding 1.2% to $13.32,

Biogen Idec

(BIIB) - Get Biogen Inc. Report

was off 0.8% at $48.91, and


(CELG) - Get Celgene Corporation Report

was losing 0.8% to $54.99.